This study is NOT currently recruiting participants.
Number
12-C-0175
Sponsoring Institute
National Cancer Institute (NCI)
Recruitment Detail
Type: Completed Study; data analyses ongoing Gender: Male & Female Min Age: 18 Years Max Age: N/A
Referral Letter Required
No
Population Exclusion(s)
Pregnant Women;Adults who are or may become unable to consent;Fetuses;Children
Keywords
Tissue Acquisition; Natural History
Recruitment Keyword(s)
None
Condition(s)
Gastrointestinal Cancer; Liver Cancer; Pancreatic Cancer; Melanoma
Investigational Drug(s)
Investigational Device(s)
Intervention(s)
Supporting Site
National Cancer Institute
The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient.
Objective:
This study will allow tissue samples obtained during the protocol screening process to be used for future and ongoing research in the NCI Surgery Branch
Eligibility:
Patients must meet the minimum eligibility criteria for an NCI surgery Branch Treatment Protocol
Design
Patients will undergo testing and evaluations as required by the appropriate NCI Surgery Branch Treatment protocol
--Back to Top--
INCLUSION CRITERIA: - Patients must be greater than or equal to 18 years of age. - Patients who have a premalignant, primary or metastatic solid tumors based upon either radiographic or biochemical testing, or histological/cytological analysis that requires surgery or biopsy as a part of the standard of care diagnosis, treatment and/or follow up. - Patients must have laboratory and physical examination parameters within acceptable limits by standard of practice guidelines prior to biopsy or surgery. - Patients must be planning to undergo surgery or biopsy as part of their treatment plan. Note: Patients will not be enrolled exclusively for the procurement of tissue samples. - Patients who agree to undergo leukapheresis must meet the following criteria: - Seronegative for HIV - Seronegative for hepatitis B surface antigen and seronegative for antibody to hepatitis C. - CBC within normal limits
- Patients must be greater than or equal to 18 years of age.
- Patients who have a premalignant, primary or metastatic solid tumors based upon either radiographic or biochemical testing, or histological/cytological analysis that requires surgery or biopsy as a part of the standard of care diagnosis, treatment and/or follow up.
- Patients must have laboratory and physical examination parameters within acceptable limits by standard of practice guidelines prior to biopsy or surgery.
- Patients must be planning to undergo surgery or biopsy as part of their treatment plan. Note: Patients will not be enrolled exclusively for the procurement of tissue samples.
- Patients who agree to undergo leukapheresis must meet the following criteria:
- Seronegative for HIV
- Seronegative for hepatitis B surface antigen and seronegative for
antibody to hepatitis C.
- CBC within normal limits
Principal Investigator
Referral Contact
For more information: